Helpline 07939 046 030

Visible Difference Equality Law Research: summary of findings

07 November 2019

Visible Difference Equality Law Research: summary of findings

Below are the results of the study carried out by Hannah Saunders Durham CELLS (Centre for Ethics and Law in the Life Sciences) a study that we previously shared with our community in 2018. 

The research aimed to explore experiences relating to visible difference equality and the law. Seventeen interviews with volunteer participants were included within the project analysis, and five key themes were identified:

Theme 1: Me and visible difference – a complex equation of how I feel

Almost everyone expressed feelings of low confidence and / or self-consciousness related to visible difference at different times of their life. But there are various factors which some people believed impacted on the way they felt - such as fluctuations in the severity of their condition, self-acceptance, gender, age and level of job experience. There was not one unified picture of ‘what helps’ and ‘what hinders’. What the accounts did suggest, though, is that visible difference cannot be understood as an isolated, sole determinant of people’s experiences; the importance of other aspects of life -  such as friends and family, pride in one’s job and in one’s own skills, or a role helping others – are also integral to the experiences recounted.  

 

Theme 2: Me, you and visible difference – balancing coping and explaining against privacy

This theme relates to how people cope with having a visible difference in their daily lives. People talked about a variety of proactive and reactive coping strategies - such as explaining, hiding one’s difference or insecurity, and taking support from relevant charities and others in a similar position. Sometimes coping strategies seemed to focus more on self-protection - such as applying for manageable roles. While explaining is a common strategy, it wasn’t always simple; people often factor in various different things when deciding whether to 'explain' their condition to others. Some people seemed to feel a conflict between a desire to explain and a resentment about having to. 

 

Theme 3: Me, visible difference and work – my health needs and my job in conflict

This theme relates to the tension between what people felt was good for their health, and what they felt was required for their jobs. People often felt conflicted between the two, or forced to prioritise one over the other. 

 

Theme 4: Me, visible difference and society – feeling that I fall between the cracks

Many participants seemed to feel that their condition made them fall between the cracks. Legally, not everyone was aware of the law, and people often did not self-identify as disabled. This created a dilemma for many people on whether to disclose a condition during recruitment.  Some wanted employers to have a more flexible approach to health, rather than a tick box 'disabled or not' approach which exacerbates this dilemma.
In health terms, the feeling of falling between the cracks related to both a lack of understanding about some conditions and, for some, a need to battle for treatment because their condition is seen as 'cosmetic' or given low priority for care. 

Socially, many people had, at some stage in their lives, felt that visible difference prevented them from fitting in; some felt overlooked, harassed or targeted in the workplace. A feeling of their condition being misunderstood or underestimated by colleagues was also commonly cited. However, there were also very many positive stories of inclusion at work; people with good friends and supportive colleagues, many of whom enjoy their job.

 

Theme 5: Me, visible difference and rights – moral duties to be wary of

In generic terms, rights were seen almost as a moral duty: something that should be enforced if needed, to stand up for myself or to prevent the same thing from happening to others. However, people were wary about the reality of enforcing rights - both in terms of  challenging discrimination, or having reasonable adjustments made (if appropriate). There was also a strong sense in some interviews that rights are only positive if handled in a certain way - there is the potential for them to become 'wrongs' if dealt with inappropriately by others. 

 

What happens now with the research?

The interviews are part of a wider research project and provide an important contribution to evaluating whether the law is working properly. The research suggests that there may be some problems with the way the law works, and that some legal changes would be beneficial, including amended definitions, and increased guidance. The researcher hopes that these findings will open a debate about these important issues.

Filter News

Filter by Date
Category
Reset

Avastin Side Effects

Jo has collated shared personal experiences, with medical and general advice on Bevacizumab (brand name Avastin)

Read More

David’s Story - Community and Acceptance

David contacted NTUK after seeing our advertising campaign at King's Cross Station in London last year. Read his story:

Read More

Today is Giving Tuesday

Call out by Karen Cockburn, Charity Director, to donate and support the NF Community

Read More

Runderpants fun run

Get your Runderpants here! Set up a fun run wearing some special fundraising pants

Read More

Meet Sarah, our new Specialist NF Nurse

Sarah will be based in Leeds, supporting families across Yorkshire and Humberside

Read More

Meet Charmaine, Our New Specialist NF Nurse

Read More

Olivia’s NF1 story

Olivia and mam Kelly share their NF1 story, highlighting school achievements and support from NTUK Specialist Nurses

Read More

Eashan’s NF1 story

'Why Run'... Eashan was diagnosed with NF1 after losing his eyesight when he was 5. His mother Jen tells his story.

Read More

2023 Awareness Campaign

Nerve Tumours UK have joined forces with RBH to raise awareness for a second successive year.

Read More

Masterclasses in NF: Constitutional Mismatch Repair Deficiency Syndrome as Differential Diagnosis to NF1/Legius Syndrome - Prof. Dr. Katharina Wimmer

Constitutional Mismatch Repair Deficiency Syndrome as Differential Diagnosis to NF1/Legius Syndrome

Prof. Dr. Katharina Wimmer, Medical University of Innsbruck

Masterclasses in NF: Rare NF1-Associated Tumors in Adults - Eric Legius & Prof. Ellen Denayer

Masterclasses in NF: Rare NF1-Associated Tumors in Adults

Eric Legius, MD, PhD, University Hospital Leuven

Prof. Ellen Denayer, University Hospital Leuven

Masterclasses in NF: Optimising Hearing Outcomes in NF2-Related Schwannomatosis - Simon Freeman

Masterclasses in NF: Optimising Hearing Outcomes in NF2-Related Schwannomatosis

Simon Freeman, MPhil FRCS, Manchester Royal Infirmary and Salford Royal Hospital

Masterclasses in NF: NF1 Dermatological Manifestations - Pierre Wolkenstein, Laura Fertitta & Sirkku Peltonen

Masterclasses in NF: NF1 Dermatological Manifestations

Pierre Wolkenstein, MD, PhD, Hopital Henri-Mondor, Paris, France

Laura Fertitta, MD, Hôpital Universitaire Henri Mondor

Sirkku Peltonen, MD, PhD, University of Gothenberg, Sweden

Masterclasses in NF: Breast Cancer in NF1 - Gareth Evans

Masterclasses in NF: Breast Cancer in NF1

Gareth Evans, MD, University of Manchester, UK

Masterclasses in NF: Pain in Non-NF2-Related Schwannomatosis - David Pang

Masterclasses in NF: Pain in Non-NF2-Related Schwannomatosis

David Pang, MD, ChB. Guys and St Thomas' Hospital NHS Trust, London

Masterclasses in NF: Distinguishing Non-NF2-Related from NF2-Related Schwannomatosis - Clinical and Genetic Approaches - Said Farschtschi

Masterclasses in NF: Distinguishing Non-NF2-Related from NF2-Related Schwannomatosis - Clinical and Genetic Approaches

Said Farschtschi, MD, University Medical Center, Hamburg-Eppendorf, Germany

Masterclasses in NF: NF1 Pre-Implantation Genetic Diagnosis - Eric Legius & Prof. Ellen Denayer

Masterclasses in NF: NF1 Pre-Implantation Genetic Diagnosis

Eric Legius, MD, PHD, University Hospital of Leuven, Belgium

Prof. Ellen Denayer, University Hospital of Leuven, Belgium

NF2 Working Together: from a tentative diagnosis and beyond

Understanding the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

NF1 Working Together Part 2: from a tentative diagnosis and beyond

Understanding the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

NF1 Working Together Part 1: from a tentative diagnosis and beyond

Understanding  the impact that a tentative diagnosis has on a parent. Information and access to the existing NTUK and Specialist Nerve Tumours medical and non medical care network.

Masterclasses in NF: Surgery in NF2 - Michel Kalamarides & Andrew King

Masterclasses in NF: Surgery in NF2

Michel Kalamarides, MD, PhD, Hôpital Pitié-Salpêtrière, Paris, France

Prof Andrew King, MBBS FRCS FRCS(SN), Salford Royal Hospital, Manchester, United Kingdom. Member of the MAB of Nerve Tumours UK

Masterclasses in NF: Cognition and Behaviour in NF1: Phenotype and Treatment Approaches - Shruti Garg, Andre Rietman

Masterclasses in NF: Cognition and Behaviour in NF1: Phenotype and Treatment Approaches

Dr Shruti Garg, MBBS, MRCPsych, MMedSci, PhD, Royal Manchester Children’s Hospital, United Kingdom. Member of the MAB of Nerve Tumours UK

Andre Rietman, PhD, Erasmus University Medical Center, Rotterdam, Netherlands

Masterclasses in NF: Emotional Challenges in NF1, NF2 and Schwannomatosis - Susie Henley, Thomas Pletschko & Verena Rosenmayr

Masterclasses in NF: Emotional Challenges in NF1, NF2 and Schwannomatosis

Susie Henley, DClinPsy, PhD, Guy’s and St Thomas’ NHS Foundation Trust, London UK

Thomas Pletschko, PhD, Medical University of Vienna, Austria

Verena Rosenmayr, Clinical Psychologist, Medical University of Vienna, Austria

Masterclasses in NF: NF1 Pediatric Management - Rianne Oostenbrink

Masterclasses in NF: NF1 Pediatric Management

Rianne Oostenbrink, MD, PhD, Erasmus University Medical Center, Rotterdam, Netherlands

Masterclasses in NF: Associated Glioma in Children - the Optic Pathway and Beyond - Amedeo Azizi

Masterclasses in NF: Associated Glioma in Children - the Optic Pathway and Beyond

Amedeo Azizi, MD, PhD, Head of the Paediatric Neurofibromatosis Program and Paediatric Neuro-Oncology Program, Medical University of Vienna, Austria

Masterclasses in NF: NF1 Orthopedic Manifestations - Eric Legius and Christophe Glorion

Masterclasses in NF: NF1 Orthopedic Manifestations

Eric Legius, MD, PhD. Head of Clinical Genetics Department of the University Hospital Leuven, Belgium

Christophe Glorion, MD, PhD, Department of Paediatric Orthopedic and Traumatologic Surgery, Hopital Necker-Enfants Malades, Paris, France. 

Masterclasses in NF: NF1 Malignant Peripheral Nerve Sheath Tumours - Rosalie Ferner and Viktor-Felix Mautner

Masterclasses in NF: NF1 Malignant Peripheral Nerve Sheath Tumours

Prof Rosalie Ferner, Consultant Neurologist and Lead Clinician for Neurofibromatosis, Guy's and St. Thomas' NHS Foundation Trust, London. Member of the MAB of Nerve Tumours UK and Trustee of Nerve Tumours UK

Viktor-Felix Mautner, MD, PhD. University Medical Centre in Hamburg-Eppendorf, Germany. Head of NF Outpatient Department

Masterclasses in NF - Neurofibromatosis Type 1: Cutaneous Neurofibromas - Pierre Wolkenstein and Sirkku Peltonen

Masterclasses in NF - Neurofibromatosis Type 1: Cutaneous Neurofibromas

Pierre Wolkenstein, MD, PhD. Hopital Henri-Mondor, Paris, France. Head of the Department of Dermatology

Sirkku Peltonen MD, PhD. University of Gothenberg, Sweden. Professor of Dermatology

INFER (International NF Educational Resources) is a series of online educational lectures for medical professionals by leading neurofibromatosis experts. The Masterclasses take place online approximately once a month, each on a different topic, and include real-time interaction between the expert presenter and the participants. The presentations are conducted in English, with real-time audio interpretation available in 6 additional languages: French, German, Italian, Portuguese, Russian, and Spanish. A recording of each INFER masterclass is then be made available online in each language for those who could not attend an event. INFER is an initiative of Children’s Tumor Foundation Europe, supported by an educational grant from AstraZeneca. https://ctfeurope.org/research/masterclasses-in-nf

BPNA Keynote Lecture - Prof Rosalie Ferner - Neurofibromatosis 1 in the 21st Century

‘Neurofibromatosis 1 in the 21st Century’

Keynote Lecture at the 48th British Paediatric Neurology Association Annual Scientific Meeting on 21st January 2022

Prof Rosalie Ferner, Consultant Neurologist and Lead Clinician for Neurofibromatosis, Guy's and St. Thomas' NHS Foundation Trust, London. Member of the MAB of Nerve Tumours UK and Trustee of Nerve Tumours UK